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Introduction
Nephrogenic adenoma (NA) is an uncommon
lesion of the urinary tract that is considered to be
induced by chronic irritative factors, such as infection,
trauma, surgery, calculi, foreign bodies, and chemical
agents.1 The first report of a case was by Davis in
1949.1 However, in 1950, the term “nephrogenic
adenoma” was introduced by Friedman and
Kuhlenbeck because the structure of NA resembled
that of a renal tubule.2 We report our clinical experience
with NA of the urinary bladder and review the relevant
literature.
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Background: Nephrogenic adenoma (NA) is a rare disease of the urinary tract. We report our clinical experience
with this disease in the urinary bladder and review the literature.
Methods: Between April 1994 and July 2004, 8 patients were diagnosed with NA of the urinary bladder: 3 men
and 5 women, aged 23–77 years (mean 49.6). Multiple predisposing factors were analyzed. The mean follow-up
time was 56 months.
Results: NA was not associated with transitional cell carcinoma in our series. All patients had recurrent urinary
tract infection. Urinary tuberculosis was diagnosed in 2 patients. Two patients had undergone previous open
urosurgery, and 4 patients had received previous endourologic management. A history of urolithiasis was found
in 1 patient. Previous long-term urinary catheterization was noted in 3 patients. Two patients had received pelvic
radiation therapy for cervical cancer. Urinary frequency and microscopic hematuria were found in all patients.
All nephrogenic adenomas were treated with transurethral resection. Recurrent nephrogenic adenomas were
diagnosed in 3 patients (median time to disease relapse, 7 months). Recurrent tumors were also treated with
the endourologic method.
Conclusion: NA is an uncommon benign metaplastic lesion occurring in the urothelium. Transurethral resection of
NA provides a definite diagnosis and relief of symptoms. The recurrence rate of NA is relatively high, so careful
and long-term follow-up is necessary. [J Chin Med Assoc 2006;69(4):166–168]
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Methods
Between April 1994 and July 2004, 8 patients (3 men
and 5 women) diagnosed with NA were included, by
a computer search, in the pathologic report database
of our hospital. Age at diagnosis of NA ranged from 23
to 77 years (mean, 49.6 years). All patients underwent
transurethral resection (TUR) for pathologic diagnosis
and relief of urinary symptoms, and were followed up
with urinary cytology and cystourethroscopy at our
urologic outpatient clinic. The mean follow-up time
was 56 months (range, 5–128 months). TUR was the
treatment of choice for recurrent cases.
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Results
The history of predisposing factors showed that
all patients had recurrent urinary tract infection.
Urinary tuberculosis was diagnosed in 2 patients
(1 prostatic tuberculosis and 1 renal tuberculosis).
These 2 patients received complete anti-tuberculosis
medical treatment. Nonendoscopic urinary tract
surgery had previously been performed in 2 patients
(ureteroneocystostomy for iatrogenic ureteral injury
in 1, and multiple urethroplasty for traumatic urethral
injury in the other). Endourologic management
had previously been used in 4 patients (TUR of the
prostate for benign prostatic enlargement in 3 patients;
1 of these 3 patients had ureteroscopic lithotripsy for
ureteral stone, and another had optic urethrotomy
for urethral stricture). Only 1 patient had a history of
urolithiasis. Long-term urinary catheterization for
urethral stricture was necessary in 3 patients (ureteral
double-J stent in 2 patients and urethral catheter in
the other). Two patients had pelvic radiation therapy
for cervical cancer.
All patients complained of urinary frequency, so
they were brought for urologic examinations. Their
urinalyses revealed microscopic hematuria. All
patients’ urine cytology findings showed some
polymorphic neutrophils, but no malignant cells.
The appearance of NA under cystourethroscopy was
mostly papillary, but 1 case showed polypoid tumor
growth (Figure 1). No lesion was larger than 1 cm in
diameter. All NAs were treated with TUR, and the
microscopic findings showed tubular structures
lined with a layer of cuboidal or hobnail epithelial
cells with uniform nuclei (Figure 2). Under regular
follow-up, NA recurred in 3 patients (once in 1
patient and twice in the other 2). The median time to
disease relapse in these 3 patients was 7 months
(range, 4–13 months). The recurrent NAs were also
treated with TUR. In our series, no malignant change
of NA was found.
Discussion
NA is an unusual lesion confined to the lamina propria
of the lower urinary tract. In 1950, Friedman and
Kuhlenbeck2 used the term “nephrogenic adenoma”
to describe a distinctive lesion of the urinary tract with
characteristic epithelial tubules resembling renal
collecting tubules. The epithelial cells are clear or
vacuolated with uniform nuclei, but without mitosis.
NA is not an extremely rare lesion, and many might
have previously been misclassified as chronic cystitis.
Clear cell adenocarcinoma also must be differentiated
from NA, because they too have similar histologic
features. The predominance of clear cells, presence of
severe atypia, necrosis, high metabolic rate, and strong
staining for P53 are factors that favor the diagnosis of
clear cell adenocarcinoma.3
NA can occur anywhere in the urinary tract, from
the renal pelvis4 to the urethra, but is most common in
the urinary bladder. In our series, all NAs were found in
the urinary bladder. Olivia and Young5 reviewed 80
cases of NA, and a male predominance of 2:1 was found.
However, our case series showed a female predominance.
Figure 2. Microscopic findings of nephrogenic adenoma show
tubular structures lined with a single layer of cuboidal epithelium
(hematoxylin and eosin, = 360).
Figure 1. Cystoscopic findings of nephrogenic adenoma show a
papillary tumor growth over the anterior wall of the urinary bladder,
similar to the picture of low-grade transitional cell carcinoma.
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The etiology of NA has not been clearly defined.
There is a history of chronic irritation or inflammation
in almost all cases. However, chronic irritation and
inflammation of the urinary tract are secondary to
predisposing factors, such as trauma, chronic infection,
previous surgery, urinary calculi, irradiation, and
urinary catheterization. Most of our cases had these
predisposing factors. NA might be associated with
chronic inflammation induced by intravesical bacillus
Calmette-Guérin treatment.6 Some reports revealed
that NA was usually found in immunosuppressed
patients following renal transplantation, so
immunosuppression may be a contributory factor.7
In our series, 2 patients (25%) with urinary tuberculosis
had received complete anti-tuberculosis medical
treatment. These 2 patients might have been in an
immunocompromised condition or had urothelium in
a state of chronic inflammation. These factors could
account for why these 2 patients had NA.
Porcaro et al8 reported on cases with commonly
presented irritative bladder symptoms, such as
frequency, dysuria, and urgency. Hematuria was often
observed. All of our cases presented with urinary
frequency and microscopic hematuria.
NA may appear polypoid, papillary, or flat under
cystoscopy, and most are localized and small, measuring
less than 1 cm in diameter.2,8 Some lesions appear
similar to low-grade transitional cell carcinoma, so the
definite diagnosis of NA is based on pathologic analysis.
TUR of the lesions is the best choice for accurate
diagnosis and symptom relief.9 Total cystectomy and
urinary diversion have rarely been performed, and only
when the lesions were extensive or symptoms were
too severe.10 A high recurrence rate (38–75%) of NA
has been found during long-term follow-up.11 Our
patients’ recurrence rate (37.5%) was also high. Despite
frequent recurrence, there have been no reports that
NA transforms to a malignant or metastatic lesion.2
All recurrent lesions should be treated with TUR.
Because of the high recurrence rate of NA, the
approach to postoperative follow-up is important.
Navarre et al12 suggested that cystourethroscopy be
given every 3 months for 2 years, every 6 months for 3
years, and then once a year in the absence of internal
infection or voiding complaints. Therefore, we advised
our patients to return for postoperative urine cytology
and cystourethroscopy in our outpatient department,
initially, every 3 months. However, because our patients
did not believe that NA was a malignant disease and
thought that cystourethroscopy was painful, compliance
with postoperative follow-up was poor, in spite of our
thorough explanation about the high recurrence rate of
the disease. Consequently, all recurrent NAs were
detected only when urinary frequency or hematuria
recurred. Therefore, our current policy is that, if
symptoms (either urinary frequency or hematuria) recur,
cystourethroscopy will be strongly suggested.
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